Intrinsic Value of S&P & Nasdaq Contact Us

REGENXBIO Inc. RGNX

NASDAQ Global Select

SharesGrow Score
54/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$26.00
+179.6%

REGENXBIO Inc. (RGNX) current share price is $9.30. The gold spot price is $4,808.10 per troy ounce. Using the formula: RGNX in gold = $9.30 × 31.1035 ÷ $4,808.10 = 0.0602 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of RGNX when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding RGNX shares over the measured period.

RGNX in US Dollars
Gold in US Dollars
RGNX in Gold (grams per share)

Real Wealth Growth Rate

RGNX
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{RGNX}_{\text{gold}}(t) = \frac{P_{\text{RGNX}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{RGNX}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{RGNX}_{\text{gold}}^{(T)}}{\text{RGNX}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{RGNX}_\text{gold}^{(0)}$ = initial gold-price, $\text{RGNX}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

RVMD
RVMD
Revolution Medicines, Inc.
$147.01
+7.86%
PTGX
PTGX
Protagonist Therapeutics, Inc.
$104.72
+7.33%
MIRM
MIRM
Mirum Pharmaceuticals, Inc.
$96.90
+0.42%
CRNX
CRNX
Crinetics Pharmaceuticals, Inc.
$39.75
+2.82%
DAWN
DAWN
Day One Biopharmaceuticals, Inc.
$21.46
-0.14%
STOK
STOK
Stoke Therapeutics, Inc.
$35.86
+2.31%
IMCR
IMCR
Immunocore Holdings plc
$31.69
+0.70%
GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$17.50
-0.28%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message